NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001791

Registered date:01/05/2009

Multicenter Phase II Study of Combination Epitope Peptides with mFOLFOX6 in Advanced/metastatic Colorectal Cancer

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedMetastatic chemo naive colorectal cancer
Date of first enrollment2009/01/01
Target sample size100
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)HLA-A2402 positive HLA-A2402 negative

Outcome(s)

Primary Outcomethe efficacy (response rate, time to progression)
Secondary Outcome1. Safety 2. Over all survival 3. Induction of immune responses 4. Progression free survival

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria1. Severe heart diseases 2. Wish for pregnancy 3. Active infection 4. Steroid or immunosuppressive therapy 5. Allergy for using epitope peptides 6. Mental and nervous disorder 7. Massive pleural or abdominal effusions 8. Peripheral nervous disorder 9. Diarrhea 10. Doctors opinion

Related Information

Contact

public contact
Name Shoichi Hazama
Address 1-1-1 Minami-Kogushi, Ube, Yamaguchi 755-8505, Japan Japan
Telephone 0836-22-2264
E-mail hazama-jsgs@umin.ac.jp
Affiliation YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE Department of Digestive Surgery and Surgical Oncology
scientific contact
Name Masaaki Oka
Address 1-1-1 Minami-Kogushi, Ube, Yamaguchi 755-8505, Japan Japan
Telephone 0836-22-2264
E-mail hazama@yamaguchi-u.ac.jp
Affiliation YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE Department of Digestive Surgery and Surgical Oncology